Featured Jobs
|
July Business Services
|
|
The Pension Design Group
|
|
Compass
|
|
3(16) Plan Customer Liaison, Enrollments Compass
|
|
July Business Services
|
|
Participant Services Representative West Coast BPAS
|
|
Hilldrup.com
|
|
Senior 401k Plan Administrator FMI Retirement Services
|
|
401k Generation
|
|
LucidHealth
|
|
DWC (The 401k Experts)
|
|
Senior Retirement Plan Administrator Daybright Financial
|
|
PPS Pension Services
|
|
Health Benefits Actuarial Consultant BPAS
|
|
ERISA Services Inc.
|
Free Publications
|
|
CMS Announces Selection of Drugs for Third Cycle of Medicare Drug Price Negotiation Program
Centers for Medicare & Medicaid Services [CMS], U.S. Department of Health and Human Services [HHS] 
[Official Guidance] Jan. 28, 2026 "[CMS] announced the selection of 15 high-cost prescription drugs covered under Medicare Part D and, for the first time, drugs payable under Medicare Part B, for the third cycle of the Medicare Drug Price Negotiation Program. CMS also selected one previously negotiated drug for the program's first renegotiations. Negotiations with participating drug companies will occur in 2026 and any negotiated and renegotiated prices will become effective January 1, 2028." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |